These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1494735)

  • 61. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy.
    Ito H; Kusaka H; Matsumoto S; Imai T
    Neurology; 1996 Nov; 47(5):1291-9. PubMed ID: 8909445
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuroleptic malignant syndrome-like condition in multiple system atrophy.
    Konagaya M; Goto Y; Matsuoka Y; Konishi T; Konagaya Y
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):120-1. PubMed ID: 9221984
    [No Abstract]   [Full Text] [Related]  

  • 63. 69-year-old man with gait disturbance and Parkinsonism.
    Marras C; Lang AE; Ang LC; Zijlmans J; Wenning GK
    Mov Disord; 2001 May; 16(3):548-61. PubMed ID: 11391758
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy.
    Konagaya M; Konagaya Y; Iida M
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1528-31. PubMed ID: 7798985
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroleptic malignant syndrome in striatonigral degeneration.
    Gibb WR
    Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methanol intoxication-induced nigrostriatal dysfunction detected using 6-[18F]fluoro-L-dopa PET.
    Airas L; Paavilainen T; Marttila RJ; Rinne J
    Neurotoxicology; 2008 Jul; 29(4):671-4. PubMed ID: 18482768
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.
    Kivi A; Trottenberg T; Kupsch A; Plotkin M; Felix R; Niehaus L
    Mov Disord; 2005 Feb; 20(2):258-60. PubMed ID: 15551348
    [No Abstract]   [Full Text] [Related]  

  • 68. [Subpial siderosis in the differential diagnosis of sporadic olivopontocerebellar atrophy].
    Arbizu T; Serra Catafau J; Capdevila A; Peres Serra J
    Neurologia; 1992 Oct; 7(8):236-7. PubMed ID: 1449843
    [No Abstract]   [Full Text] [Related]  

  • 69. Striatonigral degeneration response to levodopa therapy.
    Rajput AH; Kazi KH; Rozdilsky B
    J Neurol Sci; 1972 Jul; 16(3):331-41. PubMed ID: 5038888
    [No Abstract]   [Full Text] [Related]  

  • 70. Olivopontocerebellar atrophy and multiple system atrophy: clinical follow-up of 10 patients studied with PET.
    Schrag A; Rinne JO; Burn DJ; Mathias CJ; Marsden CD; Brooks DJ; Quinn NP
    Ann Neurol; 1998 Jul; 44(1):151-2. PubMed ID: 9667610
    [No Abstract]   [Full Text] [Related]  

  • 71. Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy.
    Ghika J; Bogousslavsky J
    Arch Neurol; 1997 Sep; 54(9):1104-8. PubMed ID: 9311353
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Progress in therapy of Parkinsonian syndrome].
    Völler GW
    Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
    [No Abstract]   [Full Text] [Related]  

  • 73. Striatonigral degeneration.
    Kan AE
    Pathology; 1978 Jan; 10(1):45-52. PubMed ID: 643319
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Slowly progressive L-DOPA nonresponsive pure akinesia due to nigropallidal degeneration: a clinicopathological case study.
    Katayama S; Watanabe C; Khoriyama T; Oka M; Mao JJ; Yamamura Y; Tahara E; Nakamura S
    J Neurol Sci; 1998 Dec; 161(2):169-72. PubMed ID: 9879699
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Parkinsonism after glycine-derivate exposure.
    Barbosa ER; Leiros da Costa MD; Bacheschi LA; Scaff M; Leite CC
    Mov Disord; 2001 May; 16(3):565-8. PubMed ID: 11391760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunohistochemical study of substance P in the substantia nigra of multiple system atrophy.
    Nomura H; Konno H; Takase S; Saito H
    Regul Pept; 1993 Jul; 46(1-2):247-50. PubMed ID: 7692506
    [No Abstract]   [Full Text] [Related]  

  • 77. Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy.
    Varanese S; Di Ruscio P; Ben M' Barek L; Thomas A; Onofrj M
    J Neurol; 2014 Feb; 261(2):441-2. PubMed ID: 24413640
    [No Abstract]   [Full Text] [Related]  

  • 78. [L-dopa + peripheral decarboxylase antagonist].
    Wiesel FA
    Lakartidningen; 1975 Oct; 72(43):4173. PubMed ID: 1177632
    [No Abstract]   [Full Text] [Related]  

  • 79. A case of hemiparkinsonism following ischemic lesion of the contralateral substantia nigra: a PET study.
    Orimo S; Amino T; Tanaka H; Mitani K; Ishiwata K; Ishii K
    Eur Neurol; 2004; 51(3):175-7. PubMed ID: 15073443
    [No Abstract]   [Full Text] [Related]  

  • 80. Pontocerebellar hypoplasia type 3 with severe vitamin A deficiency.
    Jacob FD; Hasal S; Goez HR
    Pediatr Neurol; 2011 Feb; 44(2):147-9. PubMed ID: 21215917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.